Old Web
English
Sign In
Acemap
>
authorDetail
>
C. Brock
C. Brock
The Royal Marsden NHS Foundation Trust
Medicine
Pharmacokinetics
Phases of clinical research
Maximum tolerated dose
Pharmacology
4
Papers
52
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Results of a phase 1 clinical trial investigating a combination of the oral mTOR-inhibitor Everolimus (E, RAD001) and Gemcitabine (GEM) in patients (pts) with advanced cancers
2004
Journal of Clinical Oncology
Simon Pacey
D. Rea
N Steven
C. Brock
N Knowlton
N. Shand
Katharine Hazell
Ulrike Zoellner
A. O'Donnell
Ian Judson
Show All
Source
Cite
Save
Citations (27)
Assessment of metabolism, excretion and pharmacokinetics of a single dose of [14C]-ZD6126 in patients with solid malignant tumors
2004
Journal of Clinical Oncology
Michelle Scurr
Ian Judson
C. Brock
A. O'Donnell
S Tan
E. A. Partridge
R.A. DSouza
David W. Roberts
Show All
Source
Cite
Save
Citations (9)
Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1–5 of a 3-weekly cycle in patients with advanced solid tumours
2004
British Journal of Cancer
M.J.A. de Jonge
Stan B. Kaye
Jaap Verweij
C. Brock
Sarah Reade
Michelle Scurr
L. van Doorn
C. Verheij
Walter J. Loos
C Brindley
Prakash Mistry
M Cooper
Ian Judson
Show All
Source
Cite
Save
Citations (16)
Targeted Molecular Imaging in Oncology
2002
British Journal of Cancer
C. Brock
Show All
Source
Cite
Save
Citations (0)
1